ANKRD1 acts as a transcriptional repressor of MMP13 via the AP-1 site

Molecular and Cellular Biology

Volumn 34, Issue 8, 2014, Pages 1500-1511

  Almodóvar García, Karinna ^a   Kwon, Minjae ^a   Samaras, Susan E ^a   Davidson, Jeffrey M ^a,b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANKRD1 PROTEIN; COLLAGENASE 3; CYCLOPHILIN B; MESSENGER RNA; NUCLEAR PROTEIN; NUCLEOLIN; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN C JUN; SMALL INTERFERING RNA; STROMELYSIN 2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; ANKRD1 PROTEIN, MOUSE; MMP13 PROTEIN, MOUSE; MUSCLE PROTEIN; PHOSPHOPROTEIN; REPRESSOR PROTEIN; RNA BINDING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CHRONIC WOUND; CONTROLLED STUDY; ENZYME ACTIVATION; GEL MOBILITY SHIFT ASSAY; GENE DELETION; GENE REPRESSION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOPRECIPITATION; IN VITRO STUDY; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; REAL TIME POLYMERASE CHAIN REACTION; SKIN; SKIN FIBROBLAST; WESTERN BLOTTING; WOUND HEALING; ANIMAL; CELL LINE; DRUG EFFECTS; FIBROBLAST; GENE EXPRESSION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PROMOTER REGION;

ANIMALS; CELL LINE; FIBROBLASTS; GENE EXPRESSION; MATRIX METALLOPROTEINASE 13; MICE; MICE, KNOCKOUT; MUSCLE PROTEINS; NUCLEAR PROTEINS; PHOSPHOPROTEINS; PROMOTER REGIONS, GENETIC; REPRESSOR PROTEINS; RNA, MESSENGER; RNA-BINDING PROTEINS; SEQUENCE DELETION; TRANSCRIPTION FACTOR AP-1;

EID: 84896498196     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01357-13     Document Type: Article

References (51)

1. Midwood KS, Williams LV, Schwarzbauer JE. 2004. Tissue repair and the dynamics of the extracellular matrix. Int. J. Biochem. Cell Biol. 36: 1031-1037. http://dx.doi.org/10.1016/j.biocel.2003.12.003.
2. Schultz GS, Wysocki A. 2009. Interactions between extracellular matrix and growth factors in wound healing. Wound Repair Regen. 17:153-162. http://dx.doi.org/10.1111/j.1524-475X.2009.00466.x.
3. Saaristo A, Tammela T, Farkkila A, Karkkainen M, Suominen E, Yla- Herttuala S, Alitalo K. 2006. Vascular endothelial growth factor-C accelerates diabetic wound healing. Am. J. Pathol. 169:1080-1087. http://dx.doi.org/10.2353/ajpath.2006.051251.
4. Shi Y, Reitmaier B, Regenbogen J, Slowey RM, Opalenik SR, Wolf E, Goppelt A, Davidson JM. 2005. CARP, a cardiac ankyrin repeat protein, is upregulated during wound healing and induces angiogenesis in experimental granulation tissue. Am. J. Pathol. 166:303-312. http://dx.doi.org/10.1016/S0002-9440(10)62254-7.
5. Samaras SE, Shi Y, Davidson JM. 2006. CARP: fishing for novel mechanisms of neovascularization. J. Invest. Dermatol. Symp. Proc. 11:124-131. http://dx.doi.org/10.1038/sj.jidsymp.5650014.
6. Chu W, Burns DK, Swerlick RA, Presky DH. 1995. Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. J. Biol. Chem. 270:10236-10245. http://dx.doi.org/10.1074/jbc.270.17.10236.
7. Jeyaseelan R, Poizat C, Baker RK, Abdishoo S, Isterabadi LB, Lyons GE, Kedes L. 1997. A novel cardiac-restricted target for doxorubicin. CARP, a nuclear modulator of gene expression in cardiac progenitor cells and cardiomyocytes. J. Biol. Chem. 272:22800-22808.
8. Bang ML, Mudry RE, McElhinny AS, Trombitas K, Geach AJ, Yamasaki R, Sorimachi H, Granzier H, Gregorio CC, Labeit S. 2001. Myopalladin, a novel 145-kilodalton sarcomeric protein with multiple roles in Z-disc and I-band protein assemblies. J. Cell Biol. 153:413-427. http://dx.doi.org/10.1083/jcb.153.2.413.
9. Mikhailov AT, Torrado M. 2006. The cardiac ankyrin repeat domain 1 protein: do you know enough about its dimerization properties? J. Muscle Res. Cell Motil. 27:203-204; author reply, 251-252. http://dx.doi.org/10.1007/s10974-006-9061-x.
10. Zou Y, Evans S, Chen J, Kuo HC, Harvey RP, Chien KR. 1997. CARP, a cardiac ankyrin repeat protein, is downstream in the Nkx2-5 homeobox gene pathway. Development 124:793-804.
11. Gill SE, Parks WC. 2008. Metalloproteinases and their inhibitors: regulators of wound healing. Int. J. Biochem. Cell Biol. 40:1334-1347. http://dx.doi.org/10.1016/j.biocel.2007.10.024.
12. Martin P. 1997. Wound healing: aiming for perfect skin regeneration. Science 276:75-81. http://dx.doi.org/10.1126/science.276.5309.75.
13. Ravanti L, Kahari VM. 2000. Matrix metalloproteinases in wound repair (review). Int. J. Mol. Med. 6:391-407.
14. Armstrong DG, Jude EB. 2002. The role of matrix metalloproteinases in wound healing. J. Am. Podiatr. Med. Assoc. 92:12-18.
15. Pilcher BK, Wang M, Qin XJ, Parks WC, Senior RM, Welgus HG. 1999. Role of matrix metalloproteinases and their inhibition in cutaneous wound healing and allergic contact hypersensitivity. Ann. N. Y. Acad. Sci. 878:12-24. http://dx.doi.org/10.1111/j.1749-6632.1999.tb07671.x.
16. Hartenstein B, Dittrich BT, Stickens D, Heyer B, Vu TH, Teurich S, Schorpp-Kistner M, Werb Z, Angel P. 2006. Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice. J. Invest. Dermatol. 126:486-496. http://dx.doi.org/10.1038/sj.jid.5700084.
17. Mariani TJ, Sandefur S, Roby JD, Pierce RA. 1998. Collagenase-3 induction in rat lung fibroblasts requires the combined effects of tumor necrosis factor-alpha and 12-lipoxygenase metabolites: a model of macrophage- induced, fibroblast-driven extracellular matrix remodeling during inflammatory lung injury. Mol. Biol. Cell 9:1411-1424. http://dx.doi.org/10.1091/mbc.9.6.1411.
18. Wu N, Opalenik S, Liu J, Jansen ED, Giro MG, Davidson JM. 2002. Real-time visualization of MMP-13 promoter activity in transgenic mice. Matrix Biol. 21:149-161. http://dx.doi.org/10.1016/S0945-053X(01)00 192-5.
19. Hattori N, Mochizuki S, Kishi K, Nakajima T, Takaishi H, D'Armiento J, Okada Y. 2009. MMP-13 plays a role in keratinocyte migration, angiogenesis, and contraction in mouse skin wound healing. Am. J. Pathol. 175:533-546. http://dx.doi.org/10.2353/ajpath.2009.081080.
20. Toriseva M, Laato M, Carpen O, Ruohonen ST, Savontaus E, Inada M, Krane SM, Kahari VM. 2012. MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability. PLoS One 7:e42596. http://dx.doi.org/10.1371/journal.pone.0042596.
21. Normand J, Karasek MA. 1995. A method for the isolation and serial propagation of keratinocytes, endothelial cells, and fibroblasts from a single punch biopsy of human skin. In Vitro Cell Dev. Biol. Anim. 31:447-455. http://dx.doi.org/10.1007/BF02634257.
22. Chang LS, Pan S, Pater MM, Di Mayorca G. 1985. Differential requirement for SV40 early genes in immortalization and transformation of primary rat and human embryonic cells. Virology 146:246-261. http://dx.doi.org/10.1016/0042-6822(85)90008-X.
23. Ray JL, Leach R, Herbert JM, Benson M. 2001. Isolation of vascular smooth muscle cells from a single murine aorta. Methods Cell Sci. 23:185-188. http://dx.doi.org/10.1023/A:1016357510143.
24. Xu Y, Swerlick RA, Sepp N, Bosse D, Ades EW, Lawley TJ. 1994. Characterization of expression and modulation of cell adhesion molecules on an immortalized human dermal microvascular endothelial cell line (HMEC-1). J. Invest. Dermatol. 102:833-837. http://dx.doi.org/10.1111/1523-1747.ep12382086.
25. Davidson JM, Yu F, Opalenik SR. 2013. Splinting strategies to overcome confounding wound contraction in experimental animal models. Advances Wound Care 2:142-148. http://dx.doi.org/10.1089/wound.2012.0424.
26. Yu F, Samson PC, Schaffer DK, Wikswo JP, Davidson JM. 2010.AnovelPDMS device to prevent contraction in rodent excisionalwounds. WoundRepair Regen. 18:A43. http://dx.doi.org/10.1111/j.1524-475X.2010.00581.x.
27. Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K, Granzier H, McElhinny AS, Gregorio CC, Labeit S. 2003. The muscle ankyrin repeat proteins: CARP, ankrd2/Arpp, and DARP as a family of titin filament-based stress response molecules. J. Mol. Biol. 333:951-964. http://dx.doi.org/10.1016/j.jmb.2003.09.012.
28. Samuel S, Twizere JC, Beifuss KK, Bernstein LR. 2008. Nucleolin binds specifically to an AP-1 DNA sequence and represses AP1-dependent transactivation of the matrix metalloproteinase-13 gene. Mol. Carcinog. 47:34-46. http://dx.doi.org/10.1002/mc.20358.
29. Jormsjo S, Ye S, Moritz J, Walter DH, Dimmeler S, Zeiher AM, Henney A, Hamsten A, Eriksson P. 2000. Allele-specific regulation of matrix metalloproteinase-12 gene activity is associated with coronary artery luminal dimensions in diabetic patients with manifest coronary artery disease. Circ. Res. 86:998-1003. http://dx.doi.org/10.1161/01.RES.86.9.998.
30. Mittelstadt ML, Patel RC. 2012. AP-1-mediated transcriptional repression of matrix metalloproteinase-9 by recruitment of histone deacetylase 1 in response to interferon beta. PLoS One 7:e42152. http://dx.doi.org/10.1371/journal.pone.0042152.
31. Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, BrinckerhoffCE. 2000. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor κB: differential regulation of collagenase 1 and collagenase 3. Arthritis Rheumatism 43:801-811. http://dx.doi.org/10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4.
32. Mak IW, Turcotte RE, Popovic S, Singh G, Ghert M. 2011. AP-1 as a regulator ofMMP-13in the stromal cell of giant cell tumor of bone. Biochem. Res. Int. 2011:164-197. http://dx.doi.org/10.1155/2011/164197.
33. Vincenti MP, BrinckerhoffCE. 2002. Transcriptional regulation of collagenase (MMP-1, MMP-13) genes in arthritis: integration of complex signaling pathways for the recruitment of gene-specific transcription factors. Arthritis Res. 4:157-164. http://dx.doi.org/10.1186/ar401.
34. Rodriguez JA, Orbe J, Martinez de Lizarrondo S, Calvayrac O, Rodriguez C, Martinez-Gonzalez J, Paramo JA. 2008. Metalloproteinases and atherothrombosis: MMP-10 mediates vascular remodeling promoted by inflammatory stimuli. Front. Biosci. 13:2916-2921. http://dx.doi.org/10.2741/2896.
35. Vaalamo M, Mattila L, Johansson N, Kariniemi AL, Karjalainen-Lindsberg ML, Kahari VM, Saarialho-Kere U. 1997. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J. Invest. Dermatol. 109:96-101. http://dx.doi.org/10.1111/1523-1747.ep12276722.
36. Ravanti L, Heino J, Lopez-Otin C, Kahari VM. 1999. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by threedimensional collagen is mediated by p38 mitogen-activated protein kinase. J. Biol. Chem. 274:2446-2455. http://dx.doi.org/10.1074/jbc.274.4.2446.
37. Ravanti L, Toriseva M, Penttinen R, Crombleholme T, Foschi M, Han J, Kahari VM. 2001. Expression of human collagenase-3 (MMP-13) by fetal skin fibroblasts is induced by transforming growth factor beta via p38 mitogen-activated protein kinase. FASEB J. 15:1098-1100. http://dx.doi.org/10.1096/fj.00-0588fje.
38. Balbin M, Fueyo A, Knauper V, Lopez JM, Alvarez J, Sanchez LM, Quesada V, Bordallo J, Murphy G, Lopez-Otin C. 2001. Identification and enzymatic characterization of two diverging murine counterparts of human interstitial collagenase (MMP-1) expressed at sites of embryo implantation. J. Biol. Chem. 276:10253-10262. http://dx.doi.org/10.1074/jbc. M009586200.
39. Chiang WC, Wong YK, Lin SC, Chang KW, Liu CJ. 2006. Increase of MMP-13 expression in multi-stage oral carcinogenesis and epigallocatechin- 3-gallate suppress MMP-13 expression. Oral Dis. 12:27-33. http://dx.doi.org/10.1111/j.1601-0825.2005.01151.x.
40. Decock J, Hendrickx W, Vanleeuw U, Van Belle V, Van Huffel S, Christiaens MR, Ye S, Paridaens R. 2008. Plasma MMP1 and MMP8 expression in breast cancer: protective role of MMP8 against lymph node metastasis. BMC Cancer 8:77. http://dx.doi.org/10.1186/1471-2407-8-77.
41. Yamagata K, Li X, Ikegaki S, Oneyama C, Okada M, Nishita M, Minami Y. 2012. Dissection of Wnt5a-Ror2 signaling leading to matrix metalloproteinase (MMP-13) expression. J. Biol. Chem. 287:1588-1599. http://dx.doi.org/10.1074/jbc. M111.315127.
42. Zyada MM, Shamaa AA. 2008. Is collagenase-3 (MMP-13) expression in chondrosarcoma of the jaws a true marker for tumor aggressiveness? Diagn. Pathol. 3:26. http://dx.doi.org/10.1186/1746-1596-3-26.
43. Neuhold LA, Killar L, Zhao W, Sung ML, Warner L, Kulik J, Turner J, Wu W, Billinghurst C, Meijers T, Poole AR, Babij P, DeGennaro LJ. 2001. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J. Clin. Invest. 107:35-44. http://dx.doi.org/10.1172/JCI10564.
44. Burrage PS, Mix KS, BrinckerhoffCE. 2006. Matrix metalloproteinases: role in arthritis. Front. Biosci. 11:529-543. http://dx.doi.org/10.2741/1817.
45. Granet C, Maslinski W, Miossec P. 2004. Increased AP-1 and NF-kB activation and recruitment with the combination of the proinflammatory cytokines IL-β1, tumor necrosis factor α and IL-β17 in rheumatoid synoviocytes. Arthritis Res. Ther. 6:R190-R198. http://dx.doi.org/10.1186/ar1159.
46. Chen B, Zhong L, Roush SF, Pentassuglia L, Peng X, Samaras S, Davidson JM, Sawyer DB, Lim CC. 2012. Disruption of a GATA4/Ankrd1 signaling axis in cardiomyocytes leads to sarcomere disarray: implications for anthracycline cardiomyopathy. PLoS One 7:e35743. http://dx.doi.org/10.1371/journal.pone.0035743.
47. Torrado M, Nespereira B, Lopez E, Centeno A, Castro-Beiras A, Mikhailov AT. 2005. ANKRD1 specifically binds CASQ2 in heart extracts and both proteins are co-enriched in piglet cardiac Purkinje cells. J. Mol. Cell Cardiol. 38:353-365. http://dx.doi.org/10.1016/j.yjmcc.2004.11.034.
48. Witt CC, Witt SH, Lerche S, Labeit D, Back W, Labeit S. 2008. Cooperative control of striated muscle mass and metabolism by MuRF1 and MuRF2. EMBO J. 27:350-360. http://dx.doi.org/10.1038/sj.emboj.7601952.
49. Samuel S, Beifuss KK, Bernstein LR. 2007. YB-1 binds to the MMP-13 promoter sequence and represses MMP-13 transactivation via the AP-1 site. Biochim. Biophys. Acta 1769:525-531. http://dx.doi.org/10.1016/j.bbaexp.2007.07.003.
50. Chen CY, Gherzi R, Andersen JS, Gaietta G, Jurchott K, Royer HD, Mann M, Karin M. 2000. Nucleolin and YB-1 are required for JNKmediated interleukin-2 mRNA stabilization during T-cell activation. Genes Dev. 14:1236-1248. http://dx.doi.org/10.1101/gad.14.10.1236.
51. Tsou JH, Chang KY, Wang WC, Tseng JT, Su WC, Hung LY, Chang WC, Chen BK. 2008. Nucleolin regulates c-Jun/Sp1-dependent transcriptional activation of cPLA2α in phorbol ester-treated non-small cell lung cancer A549 cells. Nucleic Acids Res. 36:217-227. http://dx.doi.org/10.1093/nar/gkm1027.